As of 2025-10-15, the Relative Valuation of Syndax Pharmaceuticals Inc (SNDX) is (68.83) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.31 USD, the upside of Syndax Pharmaceuticals Inc based on Relative Valuation is -549.6%.
The range of the Relative Valuation is (62.46) - (78.48) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.1x - 20.2x | 17.7x |
| Forward P/E multiples | 16.0x - 23.4x | 17.7x |
| Fair Price | (62.46) - (78.48) | (68.83) |
| Upside | -507.9% - -612.6% | -549.6% |
| Date | P/E |
| 2025-10-14 | -3.94 |
| 2025-10-13 | -3.91 |
| 2025-10-10 | -4.13 |
| 2025-10-09 | -4.17 |
| 2025-10-08 | -4.24 |
| 2025-10-07 | -4.23 |
| 2025-10-06 | -4.22 |
| 2025-10-03 | -4.01 |
| 2025-10-02 | -3.97 |
| 2025-10-01 | -4.03 |
| 2025-09-30 | -3.96 |
| 2025-09-29 | -4.00 |
| 2025-09-26 | -4.03 |
| 2025-09-25 | -3.86 |
| 2025-09-24 | -3.86 |
| 2025-09-23 | -3.82 |
| 2025-09-22 | -3.83 |
| 2025-09-19 | -3.80 |
| 2025-09-18 | -3.97 |
| 2025-09-17 | -3.79 |
| 2025-09-16 | -3.87 |
| 2025-09-15 | -4.07 |
| 2025-09-12 | -4.00 |
| 2025-09-11 | -4.21 |
| 2025-09-10 | -4.04 |
| 2025-09-09 | -4.10 |
| 2025-09-08 | -4.20 |
| 2025-09-05 | -4.38 |
| 2025-09-04 | -4.16 |
| 2025-09-03 | -4.15 |
| 2025-09-02 | -4.15 |
| 2025-08-29 | -4.20 |
| 2025-08-28 | -4.20 |
| 2025-08-27 | -4.18 |
| 2025-08-26 | -4.08 |
| 2025-08-25 | -4.03 |
| 2025-08-22 | -4.18 |
| 2025-08-21 | -4.07 |
| 2025-08-20 | -4.05 |
| 2025-08-19 | -3.96 |
| 2025-08-18 | -4.08 |
| 2025-08-15 | -4.05 |
| 2025-08-14 | -3.79 |
| 2025-08-13 | -3.46 |
| 2025-08-12 | -3.34 |
| 2025-08-11 | -3.22 |
| 2025-08-08 | -3.21 |
| 2025-08-07 | -3.27 |
| 2025-08-06 | -3.31 |
| 2025-08-05 | -3.23 |